1.31

5.07% -0.07

Pre-market: 1.32 0.01 +0.76%

Pulmonx Corp (LUNG)

Overview News Price History Option Chain Financials Discussions Forecast

Pulmonx Corp stock is traded at $1.31, with a volume of 1.00M. It is down -5.07% in the last 24 hours and down -21.56% over the past month. Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Previous Close:

$1.38

Open:

$1.39

24h Volume:

1.00M

Relative Volume:

0.43

Market Cap:

$53.38M

Revenue:

$68.68M

Net Income/Loss:

$-60.84M

P/E Ratio:

-0.8188

EPS:

-1.6

Net Cash Flow:

$-38.42M

1W Performance:

-17.61%

1M Performance:

-21.56%

6M Performance:

-60.90%

1Y Performance:

-78.87%

1-Day Range:

$1.31

$1.46

1-Week Range:

$1.31

$1.565

52-Week Range:

$1.31

$9.37

Pulmonx Corp Stock (LUNG) Company Profile

Name

Pulmonx Corp

Sector

Healthcare (1132)

Industry

Medical Devices (143)

Phone

650-364-0400

Address

700 CHESAPEAKE DRIVE, REDWOOD CITY

Employee

291

Twitter

Next Earnings Date

2024-10-30

Latest SEC Filings

LUNG's Discussions on Twitter

Compare LUNG with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LUNG Pulmonx Corp	1.31	56.92M	68.68M	-60.84M	-38.42M	-1.60
ABT Abbott Laboratories	123.97	219.36B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	96.60	143.81B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	360.48	139.29B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	99.35	128.70B	34.76B	4.79B	5.21B	3.7049
EW Edwards Lifesciences Corp	84.09	49.92B	5.88B	1.34B	799.60M	2.3489

Pulmonx Corp Stock (LUNG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-31-25	Downgrade	Piper Sandler	Overweight → Neutral
Mar-10-25	Initiated	D. Boral Capital	Buy
Dec-11-24	Downgrade	Citigroup	Buy → Neutral
Jun-04-24	Initiated	Lake Street	Buy
Feb-23-24	Downgrade	Wells Fargo	Overweight → Equal Weight
Sep-05-23	Initiated	Craig Hallum	Buy
Feb-27-23	Upgrade	Wells Fargo	Equal Weight → Overweight
Jan-03-23	Downgrade	BofA Securities	Neutral → Underperform
Dec-12-22	Upgrade	Citigroup	Neutral → Buy
Jul-11-22	Downgrade	Citigroup	Buy → Neutral
Mar-02-22	Resumed	BofA Securities	Neutral
Dec-08-21	Upgrade	Piper Sandler	Neutral → Overweight
Apr-01-21	Initiated	Citigroup	Buy
Mar-25-21	Initiated	Piper Sandler	Neutral
Mar-10-21	Upgrade	BofA Securities	Neutral → Buy
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Oct-26-20	Initiated	BofA Securities	Buy
Oct-26-20	Initiated	Canaccord Genuity	Buy
Oct-26-20	Initiated	Morgan Stanley	Equal-Weight
Oct-26-20	Initiated	Stifel	Buy
Oct-26-20	Initiated	Wells Fargo	Equal Weight

View All

Pulmonx Corp Stock (LUNG) Latest News

Nov 19, 2025

Technical signs of recovery in Pulmonx CorporationQuarterly Market Summary & Daily Chart Pattern Signal Reports - newser.com

Nov 19, 2025

Is Pulmonx Corporation stock attractive for hedge fundsWeekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com

Nov 19, 2025

Will Pulmonx Corporation stock sustain high P E ratios2025 Major Catalysts & Growth Focused Entry Reports - newser.com

Nov 19, 2025

Nov 18, 2025

Pulmonx Corporation (LUNG) stock price, news, quote and history - Yahoo Finance UK

Nov 18, 2025

Is Pulmonx Corporation stock trading at a premium valuationAnalyst Downgrade & Fast Entry High Yield Stock Tips - newser.com

Nov 18, 2025

Nov 16, 2025

Pulmonx (NASDAQ:LUNG) Stock Rating Upgraded by Wall Street Zen - Defense World

Nov 16, 2025

Nov 15, 2025

Is Pulmonx Corporation stock entering bullish territoryProfit Target & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 15, 2025

Can Pulmonx Corporation stock outperform in 2025 bull marketWeekly Trade Recap & Safe Capital Preservation Plans - newser.com

Nov 15, 2025

Tick level data insight on Pulmonx Corporation volatility2025 Valuation Update & Precise Buy Zone Identification - newser.com

Nov 15, 2025

Historical volatility pattern of Pulmonx Corporation visualizedTrade Analysis Report & Long-Term Safe Return Strategies - newser.com

Nov 15, 2025

Nov 14, 2025

Pulmonx Corporation (NASDAQ:LUNG) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 14, 2025

Nov 13, 2025

Pulmonx stock rating reiterated at Buy by Stifel after 3Q results - Investing.com Nigeria

Nov 13, 2025

LUNG Stock Rating: D. Boral Capital Maintains Buy Rating with $1 - GuruFocus

Nov 13, 2025

How Recent Shifts Are Rewriting the Story for Pulmonx - Yahoo Finance

Nov 13, 2025